Sarah J. Peterson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sarah J. Peterson has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Carol Braunschweig
Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois, USA
7 shared publications - Liam McKeever
Department of Clinical Nutrition, Rush University Medical Center, Chicago IL, USA
5 shared publications - Patricia Sheean
Loyola University Chicago, 2160 South First Avenue, Cuneo 439, Maywood, IL, 60153
4 shared publications Sharon Foley
Department of Clinical Nutrition, College of Health Sciences Rush University Medical Center Chicago IL USA
3 shared publications- Yimin Chen
University of Idaho Moscow Idaho USA
3 shared publications - Ainsley Malone
The American Society for Parenteral and Enteral Nutrition Silver Spring MD USA
2 shared publications
Latest Publications
- Open Access
- 26 March 2026
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (4) , 462-485
Guidelines for replacement of a balloon gastrostomy tube in infants and pediatric patients: The American Society for Parenteral and Enteral Nutrition
Background: Balloon gastrostomy tube (BGT) placements are increasing due to their ability to facilitate care of medically complex children. Management for routine and nonroutine tube replacement, including verification of proper replacement, lacks standardization, varying widely among different institutions and settings. Currently, no overall standard of care exists for placement verification following BGT replacement, which can occur anywhere. This guideline provides recommendations on topics surrounding best practices, timing, and education confirming newly replaced BGTs. Methods: An interdisciplinary team developed key questions and performed a systematic search of the PubMed/MEDLINE, EMBASE, CINAHL, and Cochrane Central databases from January 2008 to October 2025. Recommendations were developed for questions concerning timing of routine BGT replacement, weighing the impact of comorbidities and extenuating circumstances, standard and additional methods to confirm BGT replacement position, confirmation of placement when the BGT is traumatically or accidentally dislodged, and how care bundles and clinician education around BGT replacement impact patient outcomes. Results: Three studies were included (one validation and two pre‐post studies). Recommendations were made for when additional measures beyond aspiration of gastric contents (e.g., radiographic contrast study) are indicated, use of ultrasound in lieu of a contrast study, what care bundle components improve patient outcomes, and what topics should be covered in clinician education for BGT replacement confirmation. Conclusion: This guideline provides placement confirmation guidance for clinicians who perform routine and nonroutine BGT replacements, identifies areas for research, and suggests the use of care bundles to standardize care of this population. This paper was approved by the ASPEN Board of Directors.
- 26 March 2026
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (4) , 462-485
Open AccessGuidelines for replacement of a balloon gastrostomy tube in infants and pediatric patients: The American Society for Parenteral and Enteral Nutrition
Background: Balloon gastrostomy tube (BGT) placements are increasing due to their ability to facilitate care of medically complex children. Management for routine and nonroutine tube replacement, including verification of proper replacement, lacks standardization, varying widely among different institutions and settings. Currently, no overall standard of care exists for placement verification following BGT replacement, which can occur anywhere. This guideline provides recommendations on topics surrounding best practices, timing, and education confirming newly replaced BGTs. Methods: An interdisciplinary team developed key questions and performed a systematic search of the PubMed/MEDLINE, EMBASE, CINAHL, and Cochrane Central databases from January 2008 to October 2025. Recommendations were developed for questions concerning timing of routine BGT replacement, weighing the impact of comorbidities and extenuating circumstances, standard and additional methods to confirm BGT replacement position, confirmation of placement when the BGT is traumatically or accidentally dislodged, and how care bundles and clinician education around BGT replacement impact patient outcomes. Results: Three studies were included (one validation and two pre‐post studies). Recommendations were made for when additional measures beyond aspiration of gastric contents (e.g., radiographic contrast study) are indicated, use of ultrasound in lieu of a contrast study, what care bundle components improve patient outcomes, and what topics should be covered in clinician education for BGT replacement confirmation. Conclusion: This guideline provides placement confirmation guidance for clinicians who perform routine and nonroutine BGT replacements, identifies areas for research, and suggests the use of care bundles to standardize care of this population. This paper was approved by the ASPEN Board of Directors.
- Top Cited PapersOpen Access
- 3 March 2026
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (3) , 274-338
Guidelines for nutrition in adults with head and neck cancer: The American Society for Parenteral and Enteral Nutrition
Background: Head and neck cancer represents the seventh most common cancer diagnosis globally. Maintaining sufficient nutrition is important for preventing malnutrition (undernutrition) and muscle wasting, which contribute to worse outcomes, although many patients are unable to maintain adequate oral intake throughout treatment. This guideline provides practice guidance on nutrition care for patients with head and neck cancer. Methods: An interdisciplinary team developed key questions and scanned results from a systematic search of the PubMed, EMBASE, CINAHL, and Cochrane Central databases back to 2001. Recommendations were created for key questions concerning timing and duration of nutrition support (early vs delayed enteral nutrition [EN], postoperative feeding, and perioperative dietitian intervention), frequency of dietitian and speech pathology consultations, nutrition screening and assessment, macronutrient requirements, enteral access devices, adjunctive strategies (appetite stimulants and continuation of oral intake alongside EN), specialized nutrients (arginine, glutamine, ω‐3, and immunonutrition), and interdisciplinary care. Results: Ninety‐two studies were included. Recommendations were made supporting early initiation of EN when oral intake is inadequate, nutrition within 24 h after surgery, weekly consultation with a dietitian during radiotherapy, malnutrition screening and assessment with validated tools, interdisciplinary models of care, dietitian involvement before and after surgery, and when to consider use of specialized nutrients. Recommendations are also provided for protein intake (1.2–1.5 g/kg/day) and energy intake (≥30 kcal/kg/day). Conclusion: This guideline provides guidance for the nutrition care of patients with head and neck cancer, identifies research gaps, and calls for standardized outcome reporting to further the state of the evidence. This paper was approved by the ASPEN Board of Directors.
- 3 March 2026
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (3) , 274-338
Top Cited PapersOpen AccessGuidelines for nutrition in adults with head and neck cancer: The American Society for Parenteral and Enteral Nutrition
Background: Head and neck cancer represents the seventh most common cancer diagnosis globally. Maintaining sufficient nutrition is important for preventing malnutrition (undernutrition) and muscle wasting, which contribute to worse outcomes, although many patients are unable to maintain adequate oral intake throughout treatment. This guideline provides practice guidance on nutrition care for patients with head and neck cancer. Methods: An interdisciplinary team developed key questions and scanned results from a systematic search of the PubMed, EMBASE, CINAHL, and Cochrane Central databases back to 2001. Recommendations were created for key questions concerning timing and duration of nutrition support (early vs delayed enteral nutrition [EN], postoperative feeding, and perioperative dietitian intervention), frequency of dietitian and speech pathology consultations, nutrition screening and assessment, macronutrient requirements, enteral access devices, adjunctive strategies (appetite stimulants and continuation of oral intake alongside EN), specialized nutrients (arginine, glutamine, ω‐3, and immunonutrition), and interdisciplinary care. Results: Ninety‐two studies were included. Recommendations were made supporting early initiation of EN when oral intake is inadequate, nutrition within 24 h after surgery, weekly consultation with a dietitian during radiotherapy, malnutrition screening and assessment with validated tools, interdisciplinary models of care, dietitian involvement before and after surgery, and when to consider use of specialized nutrients. Recommendations are also provided for protein intake (1.2–1.5 g/kg/day) and energy intake (≥30 kcal/kg/day). Conclusion: This guideline provides guidance for the nutrition care of patients with head and neck cancer, identifies research gaps, and calls for standardized outcome reporting to further the state of the evidence. This paper was approved by the ASPEN Board of Directors.
- 27 June 2025
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 41 (1) , 291-303
Advanced nutrition support therapy practices of registered dietitian nutritionists: A survey of the Academy of Nutrition and Dietetics' Dietitians in Nutrition Support Dietetics Practice Group and the American Society for Parenteral and Enteral Nutrition Dietetics Practice Section
Nutrition support therapy (NST) requires continuous monitoring and interdisciplinary collaboration to optimize nutrition status and prevent complications. Registered dietitian nutritionists (RDNs) are pivotal in managing NST, using their expertise to assess malnutrition risk, evaluate suitable nutrition routes, and lead teams in evidence‐based nutrition care. However, not all RDNs operate at an expert level owing to varying education, training, and clinical experiences. A survey to determine expert‐level RDN NST practices was created and distributed through the Dietitians in Nutrition Support Dietetic Practice Group of the Academy of Nutrition and Dietetics and the Dietetics Practice Section of the American Society for Parenteral and Enteral Nutrition. The survey gathered data on demographics, practice characteristics, and frequency of and barriers to performing select expert‐level practice indicators using the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Revised 2021 Standards of Practice and Standards of Professional Performance for RDNs (competent, proficient, and expert) in Nutrition Support. A total of 668 RDNs completed the survey (12.4% response). Findings revealed that RDNs frequently performed nutrition‐focused physical examinations (83%) and determined micronutrient supplementation (59%). RDNs performed the following activities less frequently: evaluating body composition using diagnostic results (9%), inserting nasogastric/nasoenteric tubes (19%), and leading quality‐improvement initiatives (30%). Key barriers identified included lack of training/experience and institutional support, and regulatory constraints. These results underscore the need for enhanced professional development, including training programs and interprofessional collaboration, to promote RDN expert‐level NST practice and advance the dietetics profession.
- 27 June 2025
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 41 (1) , 291-303
Advanced nutrition support therapy practices of registered dietitian nutritionists: A survey of the Academy of Nutrition and Dietetics' Dietitians in Nutrition Support Dietetics Practice Group and the American Society for Parenteral and Enteral Nutrition Dietetics Practice Section
Nutrition support therapy (NST) requires continuous monitoring and interdisciplinary collaboration to optimize nutrition status and prevent complications. Registered dietitian nutritionists (RDNs) are pivotal in managing NST, using their expertise to assess malnutrition risk, evaluate suitable nutrition routes, and lead teams in evidence‐based nutrition care. However, not all RDNs operate at an expert level owing to varying education, training, and clinical experiences. A survey to determine expert‐level RDN NST practices was created and distributed through the Dietitians in Nutrition Support Dietetic Practice Group of the Academy of Nutrition and Dietetics and the Dietetics Practice Section of the American Society for Parenteral and Enteral Nutrition. The survey gathered data on demographics, practice characteristics, and frequency of and barriers to performing select expert‐level practice indicators using the Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Revised 2021 Standards of Practice and Standards of Professional Performance for RDNs (competent, proficient, and expert) in Nutrition Support. A total of 668 RDNs completed the survey (12.4% response). Findings revealed that RDNs frequently performed nutrition‐focused physical examinations (83%) and determined micronutrient supplementation (59%). RDNs performed the following activities less frequently: evaluating body composition using diagnostic results (9%), inserting nasogastric/nasoenteric tubes (19%), and leading quality‐improvement initiatives (30%). Key barriers identified included lack of training/experience and institutional support, and regulatory constraints. These results underscore the need for enhanced professional development, including training programs and interprofessional collaboration, to promote RDN expert‐level NST practice and advance the dietetics profession.
- Open Access
- 2 April 2025
- Published by Elsevier in Clinical Nutrition
- Vol. 49, 202-208
Recognizing malnutrition in adults with critical illness: Guidance statements from the Global Leadership Initiative on Malnutrition
- 2 April 2025
- Published by Elsevier in Clinical Nutrition
- Vol. 49, 202-208
Open AccessRecognizing malnutrition in adults with critical illness: Guidance statements from the Global Leadership Initiative on Malnutrition
- Open Access
- 31 March 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (4) , 405-413
Recognizing malnutrition in adults with critical illness: Guidance statements from the Global Leadership Initiative on Malnutrition
Background: Patients with critical illness may present with disease‐related malnutrition upon intensive care unit (ICU) admission. They are at risk of development and progression of malnutrition over the disease trajectory because of inflammation, dysregulated metabolism, and challenges with feeding.Methods: The Global Leadership Initiative on Malnutrition (GLIM) convened a panel of 36 clinical nutrition experts to develop consensus‐based guidance statements addressing the diagnosis of malnutrition during critical illness using a modified Delphi approach with a requirement of ≥75% agreement.Results: (1) To identify pre‐existing malnutrition, we suggest evaluation within 48 h of ICU admission when feasible (100% agreement) or within 4 days (94% agreement). (2) To identify the development and progression of malnutrition, we suggest re‐evaluation of all patients every 7–10 days (97% agreement). (3) To identify progressive loss of muscle mass, we suggest evaluation of muscle mass as soon as feasible (92% agreement) and again after 7–10 days (89% agreement). (4) To identify the development and progression of malnutrition before and after ICU discharge, we suggest re‐evaluating nutrition status before ICU discharge and during clinical visits that follow (100% agreement).Conclusion: Research using consistent etiologic and phenotypic variables offers great potential to assess the efficacy of nutrition interventions for critically ill patients with malnutrition. Assessment of these variables during and beyond the ICU stay will clarify the trajectory of malnutrition and enable exploration of impactful treatment modalities at each juncture. GLIM offers a diagnostic approach that can be used to identify malnutrition in critically ill patients.
- 31 March 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (4) , 405-413
Open AccessRecognizing malnutrition in adults with critical illness: Guidance statements from the Global Leadership Initiative on Malnutrition
Background: Patients with critical illness may present with disease‐related malnutrition upon intensive care unit (ICU) admission. They are at risk of development and progression of malnutrition over the disease trajectory because of inflammation, dysregulated metabolism, and challenges with feeding.Methods: The Global Leadership Initiative on Malnutrition (GLIM) convened a panel of 36 clinical nutrition experts to develop consensus‐based guidance statements addressing the diagnosis of malnutrition during critical illness using a modified Delphi approach with a requirement of ≥75% agreement.Results: (1) To identify pre‐existing malnutrition, we suggest evaluation within 48 h of ICU admission when feasible (100% agreement) or within 4 days (94% agreement). (2) To identify the development and progression of malnutrition, we suggest re‐evaluation of all patients every 7–10 days (97% agreement). (3) To identify progressive loss of muscle mass, we suggest evaluation of muscle mass as soon as feasible (92% agreement) and again after 7–10 days (89% agreement). (4) To identify the development and progression of malnutrition before and after ICU discharge, we suggest re‐evaluating nutrition status before ICU discharge and during clinical visits that follow (100% agreement).Conclusion: Research using consistent etiologic and phenotypic variables offers great potential to assess the efficacy of nutrition interventions for critically ill patients with malnutrition. Assessment of these variables during and beyond the ICU stay will clarify the trajectory of malnutrition and enable exploration of impactful treatment modalities at each juncture. GLIM offers a diagnostic approach that can be used to identify malnutrition in critically ill patients.
- Open Access
Concordance of Computed Tomography Regional Body Composition Analysis Using a Fully Automated Open-Source Neural Network versus a Reference Semi-Automated Program with Manual Correction
Quick, efficient, fully automated open-source programs to segment muscle and adipose tissues from computed tomography (CT) images would be a great contribution to body composition research. This study examined the concordance of cross-sectional areas (CSA) and densities for muscle, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intramuscular adipose tissue (IMAT) from CT images at the third lumbar (L3) between an automated neural network (test method) and a semi-automatic human-based program (reference method). Concordance was further evaluated by disease status, sex, race/ethnicity, BMI categories. Agreement statistics applied included Lin’s Concordance (CCC), Spearman correlation coefficient (SCC), Sorensen dice-similarity coefficient (DSC), and Bland–Altman plots with limits of agreement (LOA) within 1.96 standard deviation. A total of 420 images from a diverse cohort of patients (60.35 ± 10.92 years; body mass index (BMI) of 28.77 ± 7.04 kg/m2; 55% female; 53% Black) were included in this study. About 30% of patients were healthy (i.e., received a CT scan for acute illness or pre-surgical donor work-up), while another 30% had a diagnosis of colorectal cancer. The CCC, SCC, and DSC estimates for muscle, VAT, SAT were all greater than 0.80 (>0.80 indicates good performance). Agreement analysis by diagnosis showed good performance for the test method except for critical illness (DSC 0.65–0.87). Bland–Altman plots revealed narrow LOA suggestive of good agreement despite minimal proportional bias around the zero-bias line for muscle, SAT, and IMAT CSA. The test method shows good performance and almost perfect concordance for L3 muscle, VAT, SAT, and IMAT per DSC estimates, and Bland–Altman plots even after stratification by sex, race/ethnicity, and BMI categories. Care must be taken to assess the density of the CT images from critically ill patients before applying the automated neural network (test method).
Open AccessConcordance of Computed Tomography Regional Body Composition Analysis Using a Fully Automated Open-Source Neural Network versus a Reference Semi-Automated Program with Manual Correction
Quick, efficient, fully automated open-source programs to segment muscle and adipose tissues from computed tomography (CT) images would be a great contribution to body composition research. This study examined the concordance of cross-sectional areas (CSA) and densities for muscle, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intramuscular adipose tissue (IMAT) from CT images at the third lumbar (L3) between an automated neural network (test method) and a semi-automatic human-based program (reference method). Concordance was further evaluated by disease status, sex, race/ethnicity, BMI categories. Agreement statistics applied included Lin’s Concordance (CCC), Spearman correlation coefficient (SCC), Sorensen dice-similarity coefficient (DSC), and Bland–Altman plots with limits of agreement (LOA) within 1.96 standard deviation. A total of 420 images from a diverse cohort of patients (60.35 ± 10.92 years; body mass index (BMI) of 28.77 ± 7.04 kg/m2; 55% female; 53% Black) were included in this study. About 30% of patients were healthy (i.e., received a CT scan for acute illness or pre-surgical donor work-up), while another 30% had a diagnosis of colorectal cancer. The CCC, SCC, and DSC estimates for muscle, VAT, SAT were all greater than 0.80 (>0.80 indicates good performance). Agreement analysis by diagnosis showed good performance for the test method except for critical illness (DSC 0.65–0.87). Bland–Altman plots revealed narrow LOA suggestive of good agreement despite minimal proportional bias around the zero-bias line for muscle, SAT, and IMAT CSA. The test method shows good performance and almost perfect concordance for L3 muscle, VAT, SAT, and IMAT per DSC estimates, and Bland–Altman plots even after stratification by sex, race/ethnicity, and BMI categories. Care must be taken to assess the density of the CT images from critically ill patients before applying the automated neural network (test method).
- 1 December 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 46, 356-360
Relationship between blood glucose variability and muscle composition in ICU patients receiving nutrition support: A pilot study
- 1 December 2021
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 46, 356-360
Relationship between blood glucose variability and muscle composition in ICU patients receiving nutrition support: A pilot study
- 6 May 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 36 (3) , 598-605
Clinician's Guide to Understanding Effect Size, Alpha Level, Power, and Sample Size
Effect size, α level, power, and sample size are misunderstood concepts that play a major role in the design and interpretation of studies. Effect size represents the magnitude of a change in an outcome or the strength of a relationship. Often, the effect size may be more important than just relying on the α level when interpreting results from a study because it informs a researcher of the actual magnitude of the difference or relationship. Confidence intervals can also assist in making this assessment. Power represents the probability of rejecting the null hypothesis when it is false. Effect size, power, and α level are all important in the calculation of sample size needed to conduct a study. Calculating the sample size a priori and including the required number of participants is essential. Studies with small sample sizes, relative to the needed number provided from a power analysis, may lead to false negative results. Studies with grossly large sample sizes may yield statistically significant findings with small effect sizes that may not be clinically relevant. It is beneficial when all four components are clearly presented in analytic studies. Failure to include these elements may limit the ability of other researchers to replicate the study's findings and lead to difficulty when interpreting the study's results.
- 6 May 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 36 (3) , 598-605
Clinician's Guide to Understanding Effect Size, Alpha Level, Power, and Sample Size
Effect size, α level, power, and sample size are misunderstood concepts that play a major role in the design and interpretation of studies. Effect size represents the magnitude of a change in an outcome or the strength of a relationship. Often, the effect size may be more important than just relying on the α level when interpreting results from a study because it informs a researcher of the actual magnitude of the difference or relationship. Confidence intervals can also assist in making this assessment. Power represents the probability of rejecting the null hypothesis when it is false. Effect size, power, and α level are all important in the calculation of sample size needed to conduct a study. Calculating the sample size a priori and including the required number of participants is essential. Studies with small sample sizes, relative to the needed number provided from a power analysis, may lead to false negative results. Studies with grossly large sample sizes may yield statistically significant findings with small effect sizes that may not be clinically relevant. It is beneficial when all four components are clearly presented in analytic studies. Failure to include these elements may limit the ability of other researchers to replicate the study's findings and lead to difficulty when interpreting the study's results.
- 30 April 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (1) , 102-109
Prevalence of low computed tomography–measured skeletal muscle index and handgrip strength in a general medical population
Background Sarcopenia is defined as the loss of muscle mass and function and has been associated with worsened outcomes, including disability and mortality. The aim of this study was to describe the prevalence of sarcopenia in patients who had an abdominal computed tomography (CT) scan completed within 7 days of hospital admission. Methods A retrospective study was conducted. Adult patients admitted to either the general medical or surgical floor were included. Muscle function was assessed using handgrip strength (HGS, kg), completed within the first 48 hours of admission. Skeletal muscle index (SMI, kg/m2) at the third lumber region was calculated among patients who had an abdominal CT scan completed within 7 days of admission. Sarcopenia was identified by the combination of low SMI and HGS. The primary outcome was the percentage of patients diagnosed with sarcopenia. Results A total of 1318 patients were admitted; 11% (n = 141) had an abdominal CT scan completed within 7 days of admission. Only race and prevalence of malnutrition were different between patients who did and did not have a CT completed. The overall prevalence of sarcopenia was 13% (n = 18/141). Additionally, 39% of the sample was at risk for sarcopenia, with either low SMI (n = 13/141) or low HGS (n = 42/141). Conclusions Overall prevalence of sarcopenia was low, but more than one‐third of patients had either low SMI or low HGS. Minimal differences were observed between patients who did and did not have an abdominal CT scan completed upon admission.
- 30 April 2021
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 37 (1) , 102-109
Prevalence of low computed tomography–measured skeletal muscle index and handgrip strength in a general medical population
Background Sarcopenia is defined as the loss of muscle mass and function and has been associated with worsened outcomes, including disability and mortality. The aim of this study was to describe the prevalence of sarcopenia in patients who had an abdominal computed tomography (CT) scan completed within 7 days of hospital admission. Methods A retrospective study was conducted. Adult patients admitted to either the general medical or surgical floor were included. Muscle function was assessed using handgrip strength (HGS, kg), completed within the first 48 hours of admission. Skeletal muscle index (SMI, kg/m2) at the third lumber region was calculated among patients who had an abdominal CT scan completed within 7 days of admission. Sarcopenia was identified by the combination of low SMI and HGS. The primary outcome was the percentage of patients diagnosed with sarcopenia. Results A total of 1318 patients were admitted; 11% (n = 141) had an abdominal CT scan completed within 7 days of admission. Only race and prevalence of malnutrition were different between patients who did and did not have a CT completed. The overall prevalence of sarcopenia was 13% (n = 18/141). Additionally, 39% of the sample was at risk for sarcopenia, with either low SMI (n = 13/141) or low HGS (n = 42/141). Conclusions Overall prevalence of sarcopenia was low, but more than one‐third of patients had either low SMI or low HGS. Minimal differences were observed between patients who did and did not have an abdominal CT scan completed upon admission.
- 23 September 2020
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 45 (2) , 287-294
Impact of MnSOD and GPx1 Genotype at Different Levels of Enteral Nutrition Exposure on Oxidative Stress and Mortality: A Post hoc Analysis From the FeDOx Trial
Background: Converting nutrition support to energy results in mitochondrial free radical production, possibly increasing oxidative stress. Highly prevalent single nucleotide variants (SNV) exist for the genes encoding antioxidant enzymes responsible for the detoxification of reactive oxygen species. Our objective was to explore the interaction between nutrition support and genetic SNV’s for two anti‐oxidant proteins (rs4880 SNV for manganese superoxide dismutase and rs1050450 SNV for glutathione peroxidase 1) on oxidative stress and secondarily on intensive care unit (ICU) mortality.Methods: We performed a post‐hoc analysis on 34 mechanically ventilated sepsis patients from a randomized control feeding trial. Participants were dichotomized into those who carried both the rs4880 and the rs1050450 at‐risk alleles (Risk Group) versus all others (Nonrisk Group). We explored the interaction between genotype and percent time spent in the upper median of energy exposure on oxidative stress and ICU mortality.Results: Adjusting for confounders, the slope of log F2‐isoprostane levels across percentage of days spent in the upper median of daily kilocalories per kilogram (kcal/kg) was 0.01 higher in the Risk Group compared to the Non‐Risk Group (p=0.01). Every 1 percent increase in days spent in the upper median of daily kcal/kg was associated with an adjusted 10.3 percent increased odds of ICU mortality amongst participants in the Risk Group (odds ratio [OR]=1.103, p=0.06) but was highly insignificant in the Nonrisk group (OR=0.991, P=0.79).Conclusion: Nutrition support may lead to increased oxidative stress and worse clinical outcomes in a large percent of ICU patients with an at‐risk genotype.
- 23 September 2020
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 45 (2) , 287-294
Impact of MnSOD and GPx1 Genotype at Different Levels of Enteral Nutrition Exposure on Oxidative Stress and Mortality: A Post hoc Analysis From the FeDOx Trial
Background: Converting nutrition support to energy results in mitochondrial free radical production, possibly increasing oxidative stress. Highly prevalent single nucleotide variants (SNV) exist for the genes encoding antioxidant enzymes responsible for the detoxification of reactive oxygen species. Our objective was to explore the interaction between nutrition support and genetic SNV’s for two anti‐oxidant proteins (rs4880 SNV for manganese superoxide dismutase and rs1050450 SNV for glutathione peroxidase 1) on oxidative stress and secondarily on intensive care unit (ICU) mortality.Methods: We performed a post‐hoc analysis on 34 mechanically ventilated sepsis patients from a randomized control feeding trial. Participants were dichotomized into those who carried both the rs4880 and the rs1050450 at‐risk alleles (Risk Group) versus all others (Nonrisk Group). We explored the interaction between genotype and percent time spent in the upper median of energy exposure on oxidative stress and ICU mortality.Results: Adjusting for confounders, the slope of log F2‐isoprostane levels across percentage of days spent in the upper median of daily kilocalories per kilogram (kcal/kg) was 0.01 higher in the Risk Group compared to the Non‐Risk Group (p=0.01). Every 1 percent increase in days spent in the upper median of daily kcal/kg was associated with an adjusted 10.3 percent increased odds of ICU mortality amongst participants in the Risk Group (odds ratio [OR]=1.103, p=0.06) but was highly insignificant in the Nonrisk group (OR=0.991, P=0.79).Conclusion: Nutrition support may lead to increased oxidative stress and worse clinical outcomes in a large percent of ICU patients with an at‐risk genotype.